Press release
Glaucoma Therapeutics Market Size Projected to Reach USD 13.5 Billion by 2031, With 5.5% CAGR:
Glaucoma Therapeutics Market
Increases in glaucoma cases, which are a major cause of permanent blindness, are driving the global market for glaucoma therapeutics. Aging populations and increased awareness and early diagnosis support market expansion. Demand is also fueled by new treatment alternatives such as prostaglandin analogs, and combination medicines, as well as technological developments in diagnostic technologies.
Grab Sample of this Research Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16406
Current research and development endeavors concentrate on innovative medications and distribution methods, promoting market growth. The market is still being driven by the search for efficient ways to control intraocular pressure, which is a major component in the development of glaucoma.
Key Findings of Market Report
It is common for diabetics to get glaucoma. Glaucoma risk can be raised by diabetic retinopathy, the most prevalent kind of diabetic eye disease and a consequence of diabetes.
In the United States, diabetes affects around 29 million individuals. The small blood vessels in the retina are harmed by retinopathy.
About 7.7 million Americans who are 40 years of age or older are impacted by it.
The National Diabetes Statistics Report for 2022 from the Centers for Disease Control states that 37.3 million Americans have diabetes.
Providers in the global therapeutics market are carrying out carefully planned and exacting clinical studies to prove the security and effectiveness of their medications.
Market Trends for Glaucoma Therapeutics
In 2022, the hospital end-user category accounted for the majority of share. Since therapy at hospitals is less expensive than at specialist clinics, a considerable portion of the public prefers to receive treatment there first. Hospitals provide sophisticated diagnostic equipment and methods for tracking intraocular pressure and other glaucoma-related factors. This aids in the efficient and focused therapy of the disease.
Current glaucoma drugs work by increasing the outflow of aqueous humor, which lowers intraocular pressure. A more recent type of drug called netarsudil lowers intraocular pressure and increases aqueous fluid outflow. The United States Food and Drug Administration granted Alembic Pharmaceuticals final clearance in March 2023 for its shortened new drug application for Brimonidine Tartrate Ophthalmic Solution, 0.15%.
Patients with open-angle glaucoma or ocular hypertension may benefit from using this medication to lower their excessive intraocular pressure.
Customize this report according to your needs@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=16406
Global Market for Glaucoma Therapeutics: Regional Outlook
Various reasons are propelling the growth of the glaucoma therapeutics market throughout the region. These are:
In 2022, North America held the majority of the share, with Europe following closely behind. The regional market dynamics are being driven by a growth in glaucoma awareness and an aging population. The Glaucoma Research Foundation estimates that three million Americans suffer from glaucoma.
Glaucoma in older persons is six times more common beyond the age of 60. The prevalence of a well-established healthcare infrastructure and the availability of reimbursements are contributing to the increased demand for glaucoma therapies in North America.
Asia Pacific market is anticipated to grow at a rapid rate of growth throughout the projection period. The regional glaucoma treatments market statistics are driven by an increase in the prevalence of glaucoma.
In Jiangxi, China, a cross-sectional research titled "The Prevalence of Glaucoma and Its Related Factors in Rural Residents" found that 1.4% of the 5385 participants had glaucoma. Factors as such are anticipated to push the market during the forecast period.
Global Glaucoma Therapeutics Market: Key Players
To enhance their market position in glaucoma therapeutics and diversify their product offerings, significant businesses are making substantial investments in research and development. The following companies are well-known participants in the global glaucoma therapeutics market:
AbbVie Inc.
Merck & Co. Inc.
Pfizer Inc.
Novartis AG
Santen Pharmaceutical Co. Ltd.
Bausch Health Companies Inc.
Alcon
Some key developments by the players in this market are:
Global Glaucoma Therapeutics Market Segmentation
Drug Class
Prostaglandins
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors
Combination Medications
Cholinergic
End User
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Region
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Enquire Before Buying@ https://www.transparencymarketresearch.com/checkout.php?rep_id=16406<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Alani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Therapeutics Market Size Projected to Reach USD 13.5 Billion by 2031, With 5.5% CAGR: here
News-ID: 3328021 • Views: …
More Releases from transparencymarketresearch
Bentonite Market Poised for Steady Growth, Expected to Reach US$ 2.6 Bn by 2034
The global bentonite industry, valued at US$ 1.8 billion in 2023, is projected to grow at a CAGR of 3.0% from 2024 to 2034, reaching US$ 2.6 billion by 2034. This growth is driven by increasing demand across industries such as construction, oil and gas, agriculture, and cosmetics. Rising environmental awareness and the expanding use of bentonite in wastewater treatment and industrial applications further support market expansion.
Bentonite is a highly…
Ethanol Industry Poised for Steady Growth: From US$ 94.6 Billion in 2023 to US$ …
Global ethanol industry was valued at US$ 94.6 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2034, reaching approximately US$ 166.6 billion by 2034. This growth is driven by increasing demand for biofuels, stringent environmental regulations, and rising ethanol applications in industries such as automotive, pharmaceuticals, and beverages.
Ethanol, a renewable biofuel primarily derived from plant materials, has gained prominence as a sustainable…
Ion Exchange Membrane Market Forecast 6.3% CAGR Growth Expected Through 2034 | T …
The global ion exchange membrane industry was valued at US$ 1.3 billion in 2023 and is projected to grow at a CAGR of 6.3% from 2024 to 2034. Driven by increasing demand in water treatment, energy storage, and chemical processing, the market is expected to reach US$ 2.5 billion by 2034. Advancements in membrane technology, rising environmental concerns, and expanding industrial applications are key factors fueling this growth.
IEMs are semipermeable…
Electronics & Electrical Ceramics Industry Set for Steady Growth, Valued at $12. …
The global Electronics & Electrical Ceramics industry was valued at US$ 12.3 billion in 2021 and is projected to grow at a CAGR of 5.3% from 2022 to 2031, reaching approximately US$ 20.7 billion by the end of 2031. This growth is driven by increasing demand for advanced ceramics in electronic components, energy storage, and high-performance applications across industries such as telecommunications, automotive, and healthcare.
Electronics and electrical ceramics are advanced…
More Releases for Glaucoma
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis.
Download the sample report @ https://www.pharmaproff.com/request-sample/1159
The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the…
Market Spotlight: Glaucoma
Boston, MA
ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports.
Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid…
North America Glaucoma Therapeutics Market grows with growing awareness regardin …
Glaucoma Therapeutics Market: Scope and Methodology
The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study…
Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditu …
Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
